Clinical Trials Directory

Trials / Completed

CompletedNCT04958005

Salivary Interleukin-32, Interleukin-10, Interleukin-6 and Tumor Necrosis Factor-alpha Levels in Children

Evaluation of Salivary Interleukin-32, Interleukin-10, Interleukin-6 and Tumor Necrosis Factor-alpha Levels in Children With Early Childhood Caries.

Status
Completed
Phase
Study type
Observational
Enrollment
58 (actual)
Sponsor
Aydin Adnan Menderes University · Academic / Other
Sex
All
Age
3 Years – 70 Months
Healthy volunteers

Summary

This study aimed to evaluate the levels of interleukin 10, interleukin 6, interleukin 32 and tumor necrosis factor-alpha (TNF-α) in saliva of children with early childhood caries.

Detailed description

Fifty six children ( 28 with early childhood caries and 28 without early childhood caries ; age range 3-6 years) will be recruited for the study. Probing pocket depth (PPD), gingival index (GI) and plaque index (PI) will be recorded and saliva samples will be collected. Interleukin-32, Interleukin-10, Interleukin-6 and TNF-α will be analyzed in saliva samples by ELISA.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTELISAEnzim linked immunoabsorbant assay

Timeline

Start date
2021-07-01
Primary completion
2021-08-30
Completion
2021-09-30
First posted
2021-07-12
Last updated
2021-10-21

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04958005. Inclusion in this directory is not an endorsement.